Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ivermectin Reproposing for COVID-19 Treatment in Outpatients With Mild Stage

NCT04784481 is registered in ClinicalTrials.gov with Ministry of Public Health, Argentina as lead sponsor.

NCT NCT04784481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04784481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ivermectin Reproposing for COVID-19 Treatment in Outpatients With Mild Stage
Lead sponsor
Ministry of Public Health, Argentina
Phase
Phase 1/2
Overall status
Completed
Start date
September 20, 2020
Completion date
January 18, 2021
Enrollment
254 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars (severe acute respiratory syndrome)